SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: out_of_the_loop who wrote (965)9/21/1999 10:43:00 PM
From: Mad2  Read Replies (1) of 5582
 
Howard what are you saying? If QGLY claimes it and if QGLY advertizes it then I accept it. Secondly I don't question the studies having been cited by you and Dan and other GUMM supporters. Your suggestion that my answer is a bs question indicates that you would like to reduce the issues to some technical discussion about studies and reports. Do you really belive that GUMM's sucess in the market will hinge on these issues. GUMM and their stock price won't be determined by these studies. It will be determined by the by the same issues that sell other consumer products. Consumer friendliness, efficacy and marketing. As with Cold Ease I assume ZICAM is effective in reducing the duration of the common cold.....As does cold ease by the way which has been my experience. Thus will GUMM's marketing be better? Does it rate as a friendlier consumer product. To the first I don't know, but its likely to be costly. To the second the answer is no.
Your showing your true colors Howard. Wither that or you not as smart as I assume you are.
Mad2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext